Publish Your Research Online
Get Recognition - International Audience
Request for an Author Account | Login | Submit Article
|HOME||FAQ||TOP AUTHORS||FORUMS||PUBLISH ARTICLE|
Personalised Cancer Vaccine in a WeekBY: Nidhi Uppangala | Category: Industry-News | Submitted: 2010-05-21 22:47:43
Article Summary: "Scientists and researchers in Chicago were able to produce cancer vaccine in a tobacco plant. These cancer vaccines help in kick-starting the immune response against the cancer. These cancer vaccines are tailor made for patient specific tumor type..."
Antibody is a gamma globulin protein produced by B-Lymphocytes in response to an antigen. These antibodies fight and neutralize pathogens like bacteria and viruses. Human Antibodies produced in plant are known as plantibodies.
Scientists and researchers in Chicago were able to produce cancer vaccine in a tobacco plant. These cancer vaccines help in kick-starting the immune response against the cancer. These cancer vaccines are tailor made for patient specific tumor type.
But Scientists have not yet determined whether the immune response created by these vaccines were sufficient to kill cancer cells.
Method Used to produce cancer vaccine in plant:
1) Each cancer cell has got specific target (epitope) on the cell membrane but these targets are unique in each patient with same kind of cancer.
2) Patient specific target genes are identified and then cloned into viral genome using gene cloning techniques using some of the enzymes like endonuclease and ligase.
3) In this case viruses which naturally attack Tobacco plant are used for cloning the patient specific target genes.
4) Genetically modified viruses are then scratched against the tobacco leaves. Viruses transfer their genome into the leaves of the tobacco plant converting these tobacco plants into cancer vaccine producing unit.
5) A week later the cancer vaccine produced in the tobacco leaves are extracted and injected into specific patient.
6) Cancer vaccine produced in tobacco plant was successful in curing mice with cancer.
7) Team of scientists used this vaccine on some 16 patients with follicular B-cell lymphoma, a chronic, incurable disease. 70% of the patients showed improved immune response against follicular B-cell lymphoma and none of the patients experienced any major side effects.
1) Cancer can be treated without any side effects.
2) Transformed plant cells can be easily grown.
3) Producing vaccine in plants is more economical when compared to vaccine production using animal cells.
4) In a short duration patient specific vaccine can be produced.
About Author / Additional Info:
Comments on this article: (0 comments so far)
• Storing Umbilical Cord Blood: What is the Benefit?
• IPad vs Microsoft Surface Pro
• Compost Input: A Technology For Soil Restoration
• The Therapeutics of Biopharmaceutical Substances
Latest Articles in "Industry-News" category:
• The New and Easy Way to Obtain P450-metabolites and N-glucuronides For Metabolit
• Use of Jelly Fish in Preventing Bioterrorism
• Latest Biotechnology Industry News and Pharmacy News
• First Synthetic Organism
• Human Sperm Created Using Embryonic Stem Cell
• Gut Microbiota May Play a Role in Host Adiposity
• Latest in Pharmaceuticals : Sleep Drug: MK-4305 and Plastic Antibodies
• Biotech News From the World of Medicine
• Contribution of Biotechnology to the Latest Trends in Cardiac Care
• Biotechnology in the Manufacture of Textiles
• Biotechnology Companies in South Africa: Human Health
• Joule Unlimited - Pioneering Alternate Fuel and its Advantages
• Starch as Vitamin Carrier - A New Technology
• Phase IV Studies - A Market With a Proactive Approach for Growth of a Pharmaceutical Firm
• ISO-9000 Requirments, Effectiveness and Advantages
• Inoculum Preparation in Seed Lab of Fermentation Industries
• Enjoy the Benefits of Drinking a Cup of Coffee
• Understanding the Team Insurance Policy (Group Insurance)
• R&D: The Poignant Loneliness--Brief Case Studies of 8 New Listed Drugs
Important Disclaimer: All articles on this website are for general information only and is not a professional or experts advice. We do not own any responsibility for correctness or authenticity of the information presented in this article, or any loss or injury resulting from it. We do not endorse these articles, we are neither affiliated with the authors of these articles nor responsible for their content. Please see our disclaimer section for complete terms.
Copyright © 2010 biotecharticles.com - Do not copy articles from this website.
ARTICLE CATEGORIES :
| Disclaimer/Privacy/TOS | Submission Guidelines | Contact Us